How to Build Trust in the Vaccines
This week is coming to a close with truly miraculous news: In the coming days, Americans across the country are expected to begin getting vaccinated against COVID-19, a virus that emerged just a year ago. But even miraculous vaccines do little good for public health if people refuse to take them. What will persuade millions of Americans to take these new vaccines, which were developed and tested in record time?
To succeed in vaccinating the population against COVID-19, the United States must draw on the resources we already have: a population that generally supports vaccination and networks of trust that connect health-care professionals with their patients and people with their communities.
The good news is that we start from a position of strength. Contrary to popular belief, very few Americans actually oppose vaccines. For instance, only a tiny proportion of parents forgo vaccination for their children. Prior to the pandemic, vaccination rates were generally high and stable for and those of age. For example, 95 percent of children were against measles, mumps, and rubella with the MMR
You’re reading a preview, subscribe to read more.
Start your free 30 days